# Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy

> **NCT02116348** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 100 (estimated)

## Conditions studied

- Cerebral Palsy Children
- Children With Traumatic Brain Injury
- Mental Handicap
- Delayed Speech Development

## Interventions

- **DRUG:** Cerebrolysin (Nerve growth factor)

## Key facts

- **NCT ID:** NCT02116348
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02116348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02116348, "Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy". Retrieved via AI Analytics 2026-06-20 from https://api.ai-analytics.org/clinical/NCT02116348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*